Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesOveractive bladder in males
Therapeutic Advances in Urology, 10/08/09
Gomelsky A et al. – The authors consider the efficacy and safety of individual therapeutic options for lower urinary tract symptoms in men, focusing on the mainstays of medical therapy: alpha–adrenergic blockers, 5–alpha reductase inhibitors, and antimuscarinic agents. Finally, the authors aim to comment on new therapeutic strategies and targets that may one day be available for the treatment of male OAB.
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09
Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09
Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: Results in 1005 patients
Annals of Oncology, 11/10/09
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09
TVT and TVT-O for surgical treatment of primary stress urinary incontinence: prospective randomized trial
International Urogynecology Journal, 11/17/09
Fesoterodine for the treatment of urinary incontinence and overactive bladder
Therapeutics and Clinical Risk Management, 11/04/09
Article Search
Sponsor